



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
This presentation covers essential topics related to Clostridioides difficile (C. diff), including its causes, symptoms, testing practices, and recommendations for prevention. Nurses will gain valuable insights into C. diff colonization, infection, and the importance of appropriate testing.
What you will learn
Typology: Study notes
1 / 6
This page cannot be seen from the preview
Don't miss anything!
Clostridioides difficile 101 for nurses. This presentation will cover topics such as C. difficile colonization and infection as well best testing practices.
Clostridioides difficile (or “C. diff”) is a bacteria that lives in the gut. It has a spore form and a vegetative form and is transmitted to other humans by the fecal-oral-route. C. difficile spores are hardy and easily survive in the hospital environment. It is important to follow good hand hygiene practices and other infection prevention measures such as contact isolation and room cleaning to prevent spread of C. difficile from one patient to the other. C. difficile causes infection of the colon when the spore form vegetates and the resulting bacteria multiply and produce toxins that lead to inflammation of the bowel wall.
C. diff can cause mild diarrhea to severe fulminant colitis. Mild diarrhea may subside with stopping the offending antibiotic alone. In addition to diarrhea, patients may develop abdominal cramps and fever. Less commonly, they may develop vomiting if there is ileus in which motility of the gut slows down or stops). Toxic megacolon refers to significant distention of the colon due to inflammation that is associated with a risk of perforation. Therapy is based on the peripheral white cell count and creatinine and whether the patient has developed a complication such as ileus, megacolon or shock.
Patients may harbor C. diff in their guts in a dormant form. We call these patients “asymptomatic carriers” or “colonized”. For example, Infants under age 2 are often colonized with C. diff. 15% of healthy adults have been observed to be colonized with C. diff. Higher rates of colonization are found in patients evaluated at hospital admission—approximately 30%--and long-term care residents—up to 45%. Risk factors associated with carrying C. diff include chronic dialysis, recent hospitalization, immunosuppression, gastric acid suppressants and antibiotics. C. diff may persist in the gut for several months. For this reason, patients should not be re-tested after completing treatment.
There is a myth that people can identify C diff based on the color and smell of stool. Studies have shown a lack of correlation between stool color and stool smell with CDI and C. difficile testing should not be based on these parameters. One prospective study evaluated stool color in 80 controls and 4 cases of CDI. Each stool sample was imaged and given a color score on a color scale. Greenish stools were more common among the control cases. Another study correlated nurses’ response as to whether a stool was positive or not for C. difficile based on stool odor. The average correct was 45% and was not influenced by years of clinical experience of level of confidence on the ability to sniff C. difficile.
Risk factors for CDI include current or recent exposure to antibiotics, particularly clindamycin, fluoroquinolones, ampicillin and amoxicillin, and cephalosporins. Other risk factors include host factors such as older age and immunosuppression, duration of hospitalization and chemotherapy
Clinical vignette SAY: Let’s review a case to highlight some of the concepts we learnt in this presentation. A 65 yo woman is admitted to the hospital with acute cholecystitis. She undergoes cholecystectomy. On post-operative day 3 she develops 3 lose stools. Abdominal exam is unremarkable except for mild tenderness over the incision site. She is afebrile. Her white count is mildly elevated but unchanged from admission. What is the correct next step?: a) Test for C. difficile right away b) Call a colleague to inspect the stool with you, then decide c) Stop laxatives and re-evaluate need for further work up in 72 hours The correct next step is to stop laxatives and re-evaluate the need for further testing in 72 hours. As we described previously there are many reasons why hospitalized patients may have lose stools. In this case, where the patient has an alternative explanation and there are no clinical concerns for colitis, testing for C. diff is unnecessary. A positive C diff test may indicate presence of the bacteria but does not necessarily mean active disease. Hence, is important to select patients to test appropriately to avoid unnecessary treatment.
Some recommendations to avoid inappropriate testing include: